Skip to main content
Premium Trial:

Request an Annual Quote

GenoLogics Raises $8M in Private Financing; Illumina Invests

NEW YORK (GenomeWeb News) – GenoLogics today said that it has raised $8 million in a private round of financing led by Illumina, a new investor in the firm.

The Victoria, British Columbia-based bioinformatics firm said that the funds would be used to accelerate product development for future clinical applications and new desktop sequencing systems and to expand its sales and marketing functions.

Early this year, GenoLogics inked a worldwide, co-selling pact with Illumina covering its Geneus LIMS software. This agreement was followed by GenoLogics last month releasing a LIMS preconfigured package for Illumina next-generation sequencing platforms.

The amount of funding provided by Illumina and its stake in GenoLogics was not disclosed by the firms. Illumina SVP and Chief Commercial Officer Tristan Orpin will join GenoLogics' board of directors as result of the investment.

"The strategic investment by Illumina illustrates our companies' collective commitment to helping our customers overcome some of the most challenging barriers to next-generation sequencing adoption, namely data management," GenoLogics CEO Michael Ball said in a statement.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.